ACM
NUVB icon

ADAR1 Capital Management’s Nuvation Bio NUVB Stock Holding History

ADAR1 Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$187K Buy
+43,500
New +$242K 0.01% 262

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ADAR1 Capital Management's NUVB Position: Q1 2026 in Review

ADAR1 Capital Management opened a new position in Nuvation Bio (NUVB) in Q1 2026: 43,500 shares worth $187K. The stake represents 0.01% of the portfolio and ranks #262 among its holdings.

231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • ADAR1 Capital Management held 43,500 shares of Nuvation Bio worth $187K as of Q1 2026.
  • Nuvation Bio was a new ADAR1 Capital Management position in Q1 2026.
  • Nuvation Bio made up 0.01% of ADAR1 Capital Management's portfolio in Q1 2026, its #262 holding.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.